Global Erythropoietin Industry Growth and Trends Forecast to 2031

Summary

Erythropoietin is produced by interstitial fibroblasts in the kidney in close association with peritubular capillary and proximal convoluted tubule. It is also produced in perisinusoidal cells in the liver. While liver production predominates in the fetal and perinatal period, renal production is predominant during adulthood.

Erythropoietin is an essential hormone for red blood cell production. Without it, definitive erythropoiesis does not take place. Under hypoxic conditions, the kidney will produce and secrete erythropoietin to increase the production of red blood cells by targeting CFU-E, proerythroblast and basophilic erythroblast subsets in the differentiation. Erythropoietin has its primary effect on red blood cell progenitors and precursors (which are found in the bone marrow in humans) by promoting their survival through protecting these cells from apoptosis, or cell death.

In this report, we definite one unit for 1ml, except Epoetin-alfa type, which one unit means 10000units/ml

According to APO Research, The global Erythropoietin market was estimated at US$ million in 2025 and is projected to reach a revised size of US$ million by 2031, witnessing a CAGR of xx% during the forecast period 2026-2031.

North American market for Erythropoietin is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.

Asia-Pacific market for Erythropoietin is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.

Europe market for Erythropoietin is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.

The major global manufacturers of Erythropoietin include Amgen, Johnson & Johnson, Roche, Galenica, Emcure, Kyowa Hakko Kirin, 3SBio, Biocon and LG Life Sciences, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Erythropoietin, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Erythropoietin.

The Erythropoietin market size, estimations, and forecasts are provided in terms of sales volume (M Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Erythropoietin market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2020-2025. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses.

Erythropoietin Segment by Company

Amgen
Johnson & Johnson
Roche
Galenica
Emcure
Kyowa Hakko Kirin
3SBio
Biocon
LG Life Sciences

Erythropoietin Segment by Type

Epoetin-alfa
Epoetin-beta
Darbepoetin-alfa
Others

Erythropoietin Segment by Application

Anemia
Kidney Disorders
Others

Erythropoietin Segment by Region

North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Erythropoietin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Erythropoietin and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Erythropoietin.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Erythropoietin manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Erythropoietin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.


1 Market Overview

1.1 Product Definition
1.2 Global Market Growth Prospects
1.2.1 Global Erythropoietin Market Size Estimates and Forecasts (2020-2031)
1.2.2 Global Erythropoietin Sales Estimates and Forecasts (2020-2031)
1.3 Erythropoietin Market by Type
1.3.1 Epoetin-alfa
1.3.2 Epoetin-beta
1.3.3 Darbepoetin-alfa
1.3.4 Others
1.4 Global Erythropoietin Market Size by Type
1.4.1 Global Erythropoietin Market Size Overview by Type (2020-2031)
1.4.2 Global Erythropoietin Historic Market Size Review by Type (2020-2025)
1.4.3 Global Erythropoietin Forecasted Market Size by Type (2026-2031)
1.5 Key Regions Market Size by Type
1.5.1 North America Erythropoietin Sales Breakdown by Type (2020-2025)
1.5.2 Europe Erythropoietin Sales Breakdown by Type (2020-2025)
1.5.3 Asia-Pacific Erythropoietin Sales Breakdown by Type (2020-2025)
1.5.4 South America Erythropoietin Sales Breakdown by Type (2020-2025)
1.5.5 Middle East and Africa Erythropoietin Sales Breakdown by Type (2020-2025)
2 Global Market Dynamics

2.1 Erythropoietin Industry Trends
2.2 Erythropoietin Industry Drivers
2.3 Erythropoietin Industry Opportunities and Challenges
2.4 Erythropoietin Industry Restraints
3 Market Competitive Landscape by Company

3.1 Global Top Players by Erythropoietin Revenue (2020-2025)
3.2 Global Top Players by Erythropoietin Sales (2020-2025)
3.3 Global Top Players by Erythropoietin Price (2020-2025)
3.4 Global Erythropoietin Industry Company Ranking, 2023 VS 2024 VS 2025
3.5 Global Erythropoietin Major Company Production Sites & Headquarters
3.6 Global Erythropoietin Company, Product Type & Application
3.7 Global Erythropoietin Company Establishment Date
3.8 Market Competitive Analysis
3.8.1 Global Erythropoietin Market CR5 and HHI
3.8.2 Global Top 5 and 10 Erythropoietin Players Market Share by Revenue in 2024
3.8.3 2023 Erythropoietin Tier 1, Tier 2, and Tier 3
4 Erythropoietin Regional Status and Outlook

4.1 Global Erythropoietin Market Size and CAGR by Region: 2020 VS 2024 VS 2031
4.2 Global Erythropoietin Historic Market Size by Region
4.2.1 Global Erythropoietin Sales in Volume by Region (2020-2025)
4.2.2 Global Erythropoietin Sales in Value by Region (2020-2025)
4.2.3 Global Erythropoietin Sales (Volume & Value), Price and Gross Margin (2020-2025)
4.3 Global Erythropoietin Forecasted Market Size by Region
4.3.1 Global Erythropoietin Sales in Volume by Region (2026-2031)
4.3.2 Global Erythropoietin Sales in Value by Region (2026-2031)
4.3.3 Global Erythropoietin Sales (Volume & Value), Price and Gross Margin (2026-2031)
5 Erythropoietin by Application

5.1 Erythropoietin Market by Application
5.1.1 Anemia
5.1.2 Kidney Disorders
5.1.3 Others
5.2 Global Erythropoietin Market Size by Application
5.2.1 Global Erythropoietin Market Size Overview by Application (2020-2031)
5.2.2 Global Erythropoietin Historic Market Size Review by Application (2020-2025)
5.2.3 Global Erythropoietin Forecasted Market Size by Application (2026-2031)
5.3 Key Regions Market Size by Application
5.3.1 North America Erythropoietin Sales Breakdown by Application (2020-2025)
5.3.2 Europe Erythropoietin Sales Breakdown by Application (2020-2025)
5.3.3 Asia-Pacific Erythropoietin Sales Breakdown by Application (2020-2025)
5.3.4 South America Erythropoietin Sales Breakdown by Application (2020-2025)
5.3.5 Middle East and Africa Erythropoietin Sales Breakdown by Application (2020-2025)
6 Company Profiles

6.1 Amgen
6.1.1 Amgen Comapny Information
6.1.2 Amgen Business Overview
6.1.3 Amgen Erythropoietin Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Amgen Erythropoietin Product Portfolio
6.1.5 Amgen Recent Developments
6.2 Johnson & Johnson
6.2.1 Johnson & Johnson Comapny Information
6.2.2 Johnson & Johnson Business Overview
6.2.3 Johnson & Johnson Erythropoietin Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Johnson & Johnson Erythropoietin Product Portfolio
6.2.5 Johnson & Johnson Recent Developments
6.3 Roche
6.3.1 Roche Comapny Information
6.3.2 Roche Business Overview
6.3.3 Roche Erythropoietin Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Roche Erythropoietin Product Portfolio
6.3.5 Roche Recent Developments
6.4 Galenica
6.4.1 Galenica Comapny Information
6.4.2 Galenica Business Overview
6.4.3 Galenica Erythropoietin Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Galenica Erythropoietin Product Portfolio
6.4.5 Galenica Recent Developments
6.5 Emcure
6.5.1 Emcure Comapny Information
6.5.2 Emcure Business Overview
6.5.3 Emcure Erythropoietin Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Emcure Erythropoietin Product Portfolio
6.5.5 Emcure Recent Developments
6.6 Kyowa Hakko Kirin
6.6.1 Kyowa Hakko Kirin Comapny Information
6.6.2 Kyowa Hakko Kirin Business Overview
6.6.3 Kyowa Hakko Kirin Erythropoietin Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Kyowa Hakko Kirin Erythropoietin Product Portfolio
6.6.5 Kyowa Hakko Kirin Recent Developments
6.7 3SBio
6.7.1 3SBio Comapny Information
6.7.2 3SBio Business Overview
6.7.3 3SBio Erythropoietin Sales, Revenue and Gross Margin (2020-2025)
6.7.4 3SBio Erythropoietin Product Portfolio
6.7.5 3SBio Recent Developments
6.8 Biocon
6.8.1 Biocon Comapny Information
6.8.2 Biocon Business Overview
6.8.3 Biocon Erythropoietin Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Biocon Erythropoietin Product Portfolio
6.8.5 Biocon Recent Developments
6.9 LG Life Sciences
6.9.1 LG Life Sciences Comapny Information
6.9.2 LG Life Sciences Business Overview
6.9.3 LG Life Sciences Erythropoietin Sales, Revenue and Gross Margin (2020-2025)
6.9.4 LG Life Sciences Erythropoietin Product Portfolio
6.9.5 LG Life Sciences Recent Developments
7 North America by Country

7.1 North America Erythropoietin Sales by Country
7.1.1 North America Erythropoietin Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
7.1.2 North America Erythropoietin Sales by Country (2020-2025)
7.1.3 North America Erythropoietin Sales Forecast by Country (2026-2031)
7.2 North America Erythropoietin Market Size by Country
7.2.1 North America Erythropoietin Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
7.2.2 North America Erythropoietin Market Size by Country (2020-2025)
7.2.3 North America Erythropoietin Market Size Forecast by Country (2026-2031)
8 Europe by Country

8.1 Europe Erythropoietin Sales by Country
8.1.1 Europe Erythropoietin Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
8.1.2 Europe Erythropoietin Sales by Country (2020-2025)
8.1.3 Europe Erythropoietin Sales Forecast by Country (2026-2031)
8.2 Europe Erythropoietin Market Size by Country
8.2.1 Europe Erythropoietin Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
8.2.2 Europe Erythropoietin Market Size by Country (2020-2025)
8.2.3 Europe Erythropoietin Market Size Forecast by Country (2026-2031)
9 Asia-Pacific by Country

9.1 Asia-Pacific Erythropoietin Sales by Country
9.1.1 Asia-Pacific Erythropoietin Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
9.1.2 Asia-Pacific Erythropoietin Sales by Country (2020-2025)
9.1.3 Asia-Pacific Erythropoietin Sales Forecast by Country (2026-2031)
9.2 Asia-Pacific Erythropoietin Market Size by Country
9.2.1 Asia-Pacific Erythropoietin Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
9.2.2 Asia-Pacific Erythropoietin Market Size by Country (2020-2025)
9.2.3 Asia-Pacific Erythropoietin Market Size Forecast by Country (2026-2031)
10 South America by Country

10.1 South America Erythropoietin Sales by Country
10.1.1 South America Erythropoietin Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
10.1.2 South America Erythropoietin Sales by Country (2020-2025)
10.1.3 South America Erythropoietin Sales Forecast by Country (2026-2031)
10.2 South America Erythropoietin Market Size by Country
10.2.1 South America Erythropoietin Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
10.2.2 South America Erythropoietin Market Size by Country (2020-2025)
10.2.3 South America Erythropoietin Market Size Forecast by Country (2026-2031)
11 Middle East and Africa by Country

11.1 Middle East and Africa Erythropoietin Sales by Country
11.1.1 Middle East and Africa Erythropoietin Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
11.1.2 Middle East and Africa Erythropoietin Sales by Country (2020-2025)
11.1.3 Middle East and Africa Erythropoietin Sales Forecast by Country (2026-2031)
11.2 Middle East and Africa Erythropoietin Market Size by Country
11.2.1 Middle East and Africa Erythropoietin Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
11.2.2 Middle East and Africa Erythropoietin Market Size by Country (2020-2025)
11.2.3 Middle East and Africa Erythropoietin Market Size Forecast by Country (2026-2031)
12 Value Chain and Sales Channels Analysis

12.1 Erythropoietin Value Chain Analysis
12.1.1 Erythropoietin Key Raw Materials
12.1.2 Key Raw Materials Price
12.1.3 Raw Materials Key Suppliers
12.1.4 Manufacturing Cost Structure
12.1.5 Erythropoietin Production Mode & Process
12.2 Erythropoietin Sales Channels Analysis
12.2.1 Direct Comparison with Distribution Share
12.2.2 Erythropoietin Distributors
12.2.3 Erythropoietin Customers
13 Concluding Insights
14 Appendix

14.1 Reasons for Doing This Study
14.2 Research Methodology
14.3 Research Process
14.4 Authors List of This Report
14.5 Data Source
14.5.1 Secondary Sources
14.5.2 Primary Sources
14.6 Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings